Findings from the ITP World Impact Survey shed light on the most commonly reported symptoms and their severity among patients with ITP, as well as physicians’ perceptions of the frequency and severity of...
Findings from the ITP World Impact Survey shed light on the most commonly reported symptoms and their severity among patients with ITP, as well as physicians’ perceptions of the frequency and severity of...
Researchers may have uncovered an array of biomarkers associated with outcomes in immune-mediated thrombotic thrombocytopenic purpura. Until now, reliable biomarkers predictive of outcomes in this patient...
Researchers may have uncovered an array of biomarkers associated with outcomes in immune-mediated thrombotic thrombocytopenic purpura. Until now, reliable biomarkers predictive of outcomes in this patient...
In a recent study, researchers examined the relapse rate and possible influencing factors—including treatment with rituximab—in patients with autoimmune thrombotic thrombocytopenic purpura.
Shaina M. Willen, MD, pediatric hematologist at the Vanderbilt University Medical Center, discusses the recent FDA approval of L-glutamine oral powder for sickle cell disease - the first FDA-approved...
Shaina M. Willen, MD, pediatric hematologist at the Vanderbilt University Medical Center, discusses the recent FDA approval of L-glutamine oral powder for sickle cell disease - the first FDA-approved...
For this study, the researchers examined the risk factors for bleeding in adults with immune thrombocytopenia, including the platelet count thresholds. To see their results, read more.
